Praxis Precision Medicines, Inc. PRAX Debt Securities, Available-for-Sale, Unrealized Loss Position, Number of Positions
Debt Securities, Available-for-Sale, Unrealized Loss Position, Number of Positions at other companies
Other financials
Where this comes from
Reported directly by Praxis Precision Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions.
The official record: Praxis Precision Medicines, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Praxis Precision Medicines, Inc.'s debt securities, available-for-sale, unrealized loss position, number of positions.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Praxis Precision Medicines, Inc.'s debt securities, available-for-sale, unrealized loss position, number of positions?
- Praxis Precision Medicines, Inc. (PRAX) reported debt securities, available-for-sale, unrealized loss position, number of positions of $178 in Q1 2026.
- How has Praxis Precision Medicines, Inc.'s debt securities, available-for-sale, unrealized loss position, number of positions changed year-over-year?
- Praxis Precision Medicines, Inc.'s debt securities, available-for-sale, unrealized loss position, number of positions increased by 2442.9% year-over-year, from $7 to $178.